Clinical trial Recruiting at 1 site Interventional Ages 1 Month to 12 Months

Adrenaline versus dopamine for children with fluid-refractory septic shock

Official title: Comparison of the Efficacy of Renaline and Dopamine in the Treatment of Fluid Refractory Septic Shock in Children

Run by University of Health Sciences Lahore · NCT07273526 · Data updated 2026-11-12

This trial will see if adrenaline or dopamine works better to stabilize children (1 month–12 years) whose septic shock does not improve after fluid treatment.

Quick facts

Study typeInterventional
Ages1 Month to 12 Months
SexAll
Enrollment90 (estimated)
SponsorUniversity of Health Sciences Lahore
Academic / other
Locations1 site (Faisalābad, Punjab Province)
StatusRecruiting
StartedJune 1, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedDecember 9, 2025
Trial IDNCT07273526 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 1 month to 12 years with a diagnosis of fluid-refractory septic shock who meet the trial's operational definition and do not meet exclusion criteria are appropriate candidates.

Probably not a fit

Children with recent cardiopulmonary bypass, chronic systemic illnesses (like chronic kidney disease, cerebral palsy, or congenital heart disease), neuromuscular or metabolic disorders, or those treated elsewhere without records are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial enrolling children with fluid-refractory septic shock who are randomized to receive either adrenaline or dopamine. Treatments are compared by monitoring heart rate, Glasgow Coma Scale, capillary refill time, palpable peripheral pulses, urine output, and systolic blood pressure at predefined time points. The trial is conducted at a single pediatric tertiary center in Faisalabad and follows patients through early hemodynamic response. Children with recent cardiopulmonary bypass, major chronic systemic, neuromuscular, or metabolic disorders, or incomplete prior treatment records are excluded.

Why it matters

Potential benefit: If successful, the trial could identify which vasopressor restores circulation faster and reduces complications in children with fluid-refractory septic shock.

How similar studies have gone: Other pediatric and adult trials have compared epinephrine/adrenaline and dopamine with mixed results, so further randomized pediatric data are needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients of both Genders having age range between 1month and 12 years with diagnosis of fluid refractory septic shock as per operational definition.

\-

Exclusion Criteria:

* Patients with

  1. cardiopumonary Bypass during last 5 days
  2. Chronic Systemic disease like Chronic kidney Disease , cerebral palsy, congenital heart disease
  3. neuromuscular discorder
  4. Metabolic disorders
  5. Those who already had treatment at periphery for hypovolemia without any record of medication or sequential organ failure at presentation

Where it's running

  • The Children Hospital and The Institute of Child Health Faisalabad
    Faisalābad, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.